Expertise in
1
conditions

Juan M. Tiraboschi

L'hospitalet De Llobregat, CT, ES 
Expertise in
1
conditions
L'hospitalet De Llobregat, CT, ES 

Overview

Juan Tiraboschi practices practicing medicine in L'hospitalet De Llobregat, Spain.

Mr. Tiraboschi is highly rated in 1 condition, according to our data. His clinical expertise encompasses HIV/AIDS, AIDS Dementia Complex, Osteoporosis, and Encephalitis.

He is actively involved in clinical research, co-authoring 73 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

L'hospitalet De Llobregat, CT 08907, Spain
Other Locations
Barcelona, CT, Spain
Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
Enrollment Status: Terminated
Publish Date: June 26, 2024
Intervention Type: Drug
Study Drugs: GSK3640254, ABC/3TC, FTC/TAF, Dolutegravir
Study Phase: Phase 2
A Phase IIb, Randomized, Double-blind, Parallel-group Study to Assess the Efficacy, Safety, Tolerability, and Resistance Profile of GSK3640254 in Combination With Dolutegravir Compared to Dolutegravir Plus Lamivudine in HIV-1 Infected, Treatment-naïve Adults
A Phase IIb, Randomized, Double-blind, Parallel-group Study to Assess the Efficacy, Safety, Tolerability, and Resistance Profile of GSK3640254 in Combination With Dolutegravir Compared to Dolutegravir Plus Lamivudine in HIV-1 Infected, Treatment-naïve Adults
Enrollment Status: Terminated
Publish Date: December 14, 2023
Intervention Type: Drug
Study Drugs: GSK3640254, Dolutegravir, Lamivudine
Study Phase: Phase 2
Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals
Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals
Enrollment Status: Completed
Publish Date: July 06, 2022
Intervention Type: Drug
Study Drugs: Doravirine, Descovy
Study Phase: Phase 2
Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals
Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals
Enrollment Status: Completed
Publish Date: April 28, 2022
Intervention Type: Drug
Study Drugs: Doravirine, Descovy
Study Phase: Phase 3
View 3 Less Clinical Trials

73 Total Publications

Humoral Immunogenicity of SARS-CoV-2 mRNA Primary Vaccination Among People with HIV.
Humoral Immunogenicity of SARS-CoV-2 mRNA Primary Vaccination Among People with HIV.
Journal: Microorganisms
Published: March 06, 2026

Frequently Asked Questions about Juan M. Tiraboschi

Is Juan M. Tiraboschi a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Juan M. Tiraboschi is classified as an Distinguished expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Juan M. Tiraboschi participate in research or clinical trials?

Yes. Juan M. Tiraboschi has published 73 articles and abstracts on conditions like HIV/AIDS. You can view a list of Juan M. Tiraboschi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tiraboschi's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile